{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:19:26Z","timestamp":1774538366428,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Developmental Disabilities"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ridd.2022.104202","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T16:56:19Z","timestamp":1646326579000},"page":"104202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Estimation of the minimal clinically important difference on the Aberrant Behaviour Checklist\u2013Irritability (ABC-I) for people with intellectual disabilities who display aggressive challenging behaviour: A triangulated approach"],"prefix":"10.1016","volume":"124","author":[{"given":"Angela","family":"Hassiotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Melville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Jahoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Strydom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally-Ann","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Steed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afia","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny","family":"Rapaport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Marston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ridd.2022.104202_bib1","series-title":"Aberrant behavior checklist manual","author":"Aman","year":"2017"},{"key":"10.1016\/j.ridd.2022.104202_bib2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Risperidone Aggressive Behavior Study Group. Double-blind, placebo-controlled study of risperidone for the treatment of aggressive behaviors in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.ridd.2022.104202_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jir.12732","article-title":"Societal cost of childhood intellectual disability in Australia","volume":"64","author":"Arora","year":"2020","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2022.104202_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1108\/TLDR-06-2017-0025","article-title":"Toward data-based clinical decision making for adults with challenging behavior using the Behavior Problems Inventory-Short Form (BPI-S)","volume":"23","author":"Bowring","year":"2018","journal-title":"Tizard Learning Disability Review"},{"key":"10.1016\/j.ridd.2022.104202_bib5","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1017\/S0033291715001270","article-title":"Minimal clinically important difference on the Beck Depression Inventory\u2013II according to the patient\u2019s perspective","volume":"45","author":"Button","year":"2015","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.ridd.2022.104202_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pnpbp.2015.09.002","article-title":"Using venlafaxine to treat behavioral disorders in patients with autism spectrum disorder","volume":"65","author":"Carminati","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.ridd.2022.104202_bib7","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s10803-018-3703-x","article-title":"A randomized, placebo-controlled, blinded, crossover, pilot study of the effects of dextromethorphan\/quinidine for the treatment of neurobehavioral symptoms in adults with autism","volume":"50","author":"Chez","year":"2020","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.ridd.2022.104202_bib8","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ridd.2022.104202_bib9","first-page":"k3750","article-title":"DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial","volume":"363","author":"Cook","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ridd.2022.104202_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","article-title":"Understanding the minimum clinically important difference: A review of concepts and methods","volume":"7","author":"Copay","year":"2007","journal-title":"The Spine Journal: Official Journal of the North American Spine Society"},{"key":"10.1016\/j.ridd.2022.104202_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1352\/1934-9556-56.2.101","article-title":"Health services use and costs for Americans with intellectual and developmental disabilities: A national analysis","volume":"56","author":"Fujiura","year":"2018","journal-title":"Intellectual and Developmental Disabilities"},{"key":"10.1016\/j.ridd.2022.104202_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00213-004-2093-2","article-title":"Short- and long-term efficacy and safety of risperidone in adults with aggressive behavior disorders","volume":"179","author":"Gagiano","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ridd.2022.104202_bib13","first-page":"62","article-title":"Mortality in people with intellectual disabilities in England","volume":"61","author":"Glover","year":"2017","journal-title":"JIDR"},{"key":"10.1016\/j.ridd.2022.104202_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e6664","article-title":"Melatonin for sleep problems in children with neurodevelopmental disorders: Randomised double masked placebo controlled trial","volume":"345","author":"Gringras","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ridd.2022.104202_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1192\/bjp.bp.109.076646","article-title":"Applied behaviour analysis and standard treatment in intellectual disability: 2-year outcomes","volume":"198","author":"Hassiotis","year":"2011","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.ridd.2022.104202_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/bjp.2017.34","article-title":"Clinical outcomes of staff training in positive behaviour support to reduce challenging behaviour in adults with intellectual disability: Cluster randomised controlled trial","volume":"212","author":"Hassiotis","year":"2018","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.ridd.2022.104202_bib17","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2009.08111747","article-title":"Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities","volume":"166","author":"Hassiotis","year":"2009","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.ridd.2022.104202_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00019053-200018050-00001","article-title":"The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?","volume":"18","author":"Hays","year":"2000","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ridd.2022.104202_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/cap.2005.15.682","article-title":"A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders","volume":"15","author":"Hellings","year":"2005","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.ridd.2022.104202_bib20","series-title":"Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020)","year":"2020"},{"key":"10.1016\/j.ridd.2022.104202_bib21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jar.12833","article-title":"Trends over time in the management of long-term conditions in primary health care for adults with intellectual disabilities, and the health care inequality gap with the general population","volume":"34","author":"Hughes-McCormack","year":"2021","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"key":"10.1016\/j.ridd.2022.104202_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0005-7894(84)80002-7","article-title":"Psychotherapy outcome research: Methods for reporting variability and evaluating clinical significance","volume":"15","author":"Jacobson","year":"1984","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.ridd.2022.104202_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: A statistical approach to defining meaningful change in psychotherapy research","volume":"59","author":"Jacobson","year":"1991","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.ridd.2022.104202_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jir.12554","article-title":"High health care costs among adults with intellectual and developmental disabilities: A population\u2010based study","volume":"63","author":"Lunsky","year":"2019","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2022.104202_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.ridd.2022.104202_bib26","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jama.2014.13128","article-title":"Minimal clinically important difference: Defining what really matters to patients","volume":"312","author":"McGlothlin","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ridd.2022.104202_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.dhjo.2019.01.005","article-title":"Prevalence of cerebral palsy, intellectual disability, hearing loss, and blindness, National Health Interview Survey, 2009\u20132016","volume":"12","author":"McGuire","year":"2019","journal-title":"Disability and Health Journal"},{"key":"10.1016\/j.ridd.2022.104202_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fpsyt.2016.00002","article-title":"Oxytocin for male subjects with autism spectrum disorder and comorbid intellectual disabilities: A randomized pilot study","volume":"7","author":"Munesue","year":"2016","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.ridd.2022.104202_bib29","unstructured":"National Institute for Health Care and Excellence. (2015). Challenging behaviour and learning disabilities: prevention and interventions for children with learning disabilities whose behaviour challenges (NICE guideline 11 methods). [PDF]. Retrieved from \u3008https:\/\/www.nice.org.uk\/guidance\/ng11\u3009, (accessed 05.21)."},{"key":"10.1016\/j.ridd.2022.104202_bib30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Medical Care"},{"key":"10.1016\/j.ridd.2022.104202_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jir.12584","article-title":"Is risperidone effective in reducing challenging behaviours in individuals with intellectual disabilities after 1 year or longer use? A placebo-controlled, randomised, double-blind discontinuation study","volume":"63","author":"Ramerman","year":"2019","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2022.104202_bib32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and aggressive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"Journal of the American Academy of Child Adolescent Psychiatry"},{"key":"10.1016\/j.ridd.2022.104202_bib33","first-page":"l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Edition)"},{"key":"10.1016\/j.ridd.2022.104202_bib34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clnu.2019.02.028","article-title":"A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome","volume":"39","author":"de la Torre","year":"2020","journal-title":"Clinical Nutrition"},{"issue":"21","key":"10.1016\/j.ridd.2022.104202_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17210","article-title":"A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities","volume":"17","author":"Willner","year":"2013","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.ridd.2022.104202_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1179\/2042618612Y.0000000001","article-title":"Clinimetrics corner: A closer look at the minimal clinically important difference (MCID)","volume":"20","author":"Wright","year":"2012","journal-title":"The Journal of Manual & Manipulative Therapy"},{"issue":"4","key":"10.1016\/j.ridd.2022.104202_bib37","doi-asserted-by":"crossref","first-page":"e20190811","DOI":"10.1542\/peds.2019-0811","article-title":"Prevalence and trends of developmental disabilities among children in the United States: 2009\u20132017","volume":"144","author":"Zablotsky","year":"2019","journal-title":"Pediatrics"}],"container-title":["Research in Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422222000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422222000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:01:14Z","timestamp":1760194874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891422222000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":37,"alternative-id":["S0891422222000324"],"URL":"https:\/\/doi.org\/10.1016\/j.ridd.2022.104202","relation":{},"ISSN":["0891-4222"],"issn-type":[{"value":"0891-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of the minimal clinically important difference on the Aberrant Behaviour Checklist\u2013Irritability (ABC-I) for people with intellectual disabilities who display aggressive challenging behaviour: A triangulated approach","name":"articletitle","label":"Article Title"},{"value":"Research in Developmental Disabilities","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ridd.2022.104202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104202"}}